AIM
GILD icon

Advyzon Investment Management’s Gilead Sciences GILD Stock Holding History

Advyzon Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
8,093
+568
+8% +$74.8K 0.07% 255
2026
Q1 		$1.05M Sell
7,525
-259
-3% -$36.3K 0.09% 218
2025
Q4 		$955K Buy
7,784
+4,890
+169% +$594K 0.11% 188
2025
Q3 		$321K Buy
2,894
+811
+39% +$92.2K 0.06% 308
2025
Q2 		$231K Buy
2,083
+135
+7% +$14.4K 0.05% 332
2025
Q1 		$218K Sell
1,948
-2,575
-57% -$266K 0.08% 234
2024
Q4 		$418K Buy
+4,523
New +$407K 0.16% 118

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advyzon Investment Management's GILD Position: Q2 2026 in Review

Advyzon Investment Management increased its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, buying an estimated $74.8K and bringing the position to 8,093 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #255.

Advyzon Investment Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Advyzon Investment Management held 8,093 shares of Gilead Sciences worth $1.02M as of Q2 2026.
  • Advyzon Investment Management bought 568 Gilead Sciences shares in Q2 2026, an estimated $74.8K.
  • Gilead Sciences made up 0.07% of Advyzon Investment Management's portfolio in Q2 2026, its #255 holding.
  • Advyzon Investment Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Advyzon Investment Management's Gilead Sciences position peaked at $1.05M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.